Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

88
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
88
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

135
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
135
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

125
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
125
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

228
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
228
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

39
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
39
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

179
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
179

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention.

Diabetes care·2025
Same author

Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matter.

Diabetologia·2025
Same author

Type 1 Diabetes TrialNet: Leading the Charge in Disease Prediction, Prevention, and Immunotherapeutic Mechanistic Understanding.

Diabetes care·2025
Same author

Evolving epigenomics of immune cells in type 1 diabetes at single nuclei resolution.

Research square·2025
Same author

Looking back at the TEDDY study: lessons and future directions.

Nature reviews. Endocrinology·2024
Same author

Risk of celiac disease autoimmunity is modified by interactions between CD247 and environmental exposures.

Scientific reports·2024
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2025

Measuring Delay Discounting in Humans Using an Adjusting Amount Task
07:47

Measuring Delay Discounting in Humans Using an Adjusting Amount Task

Published on: January 9, 2016

15.4K

A discrete approximation method for modeling interval-censored multistate data.

Lu You1, Xiang Liu1, Jeffrey Krischer1

  • 1Health Informatics Institute, University of South Florida, Tampa, Florida, USA.

Statistics in Medicine
|April 10, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a novel method for analyzing interval-censored multistate data in disease progression studies. The approach simplifies complex data using approximations and data augmentation, improving disease event analysis.

Keywords:
data augmentationinterval censoringmultistate modelproportional hazards modeltime‐to‐event data

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

Related Experiment Videos

Last Updated: Jun 28, 2025

Measuring Delay Discounting in Humans Using an Adjusting Amount Task
07:47

Measuring Delay Discounting in Humans Using an Adjusting Amount Task

Published on: January 9, 2016

15.4K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

Area of Science:

  • Biostatistics
  • Medical Statistics
  • Longitudinal Data Analysis

Background:

  • Longitudinal studies often involve interval-censored data due to periodic monitoring.
  • Disease progression monitoring requires robust statistical methods for interval-censored multistate data.

Purpose of the Study:

  • To propose a new method for analyzing interval-censored multistate data.
  • To apply a proportional hazards model with nonparametric hazard functions.
  • To improve the analysis of disease progression in longitudinal studies.

Main Methods:

  • Developed a method using approximation and data augmentation for interval-censored multistate data.
  • Utilized a proportional hazards model with nonparametric time-dependent hazard rates.
  • Employed the expectation-maximization algorithm for parameter estimation.

Main Results:

  • The proposed method effectively handles interval-censored multistate data.
  • Numerical studies demonstrated the performance of the new statistical approach.
  • Successfully applied the method to analyze coronary allograft vasculopathy data.

Conclusions:

  • The new method offers a valuable tool for analyzing complex longitudinal disease data.
  • This approach enhances understanding of disease progression with interval-censored events.
  • The technique is applicable to real-world medical research, such as heart transplant outcomes.